切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (06) : 518 -522. doi: 10.3877/cma.j.issn.2095-3224.2016.06.013

所属专题: 文献

综述

长链非编码RNA在结直肠癌中的研究现状
梁新军1,(), 臧爱华1   
  1. 1. 430079 武汉,湖北省肿瘤医院腹部内科
  • 收稿日期:2016-07-23 出版日期:2016-12-25
  • 通信作者: 梁新军
  • 基金资助:
    武汉市科技局科技计划资助项目(No.2013062301010813); 武汉市晨光计划资助项目(No.2015070404010204)

Research progress of long non-coding RNA in colorectal cancer

Xinjun Liang1,(), Aihua Zang1   

  1. 1. Department of Gastroenterology, Hubei Cancer Hospital, Wuhan 430071, China
  • Received:2016-07-23 Published:2016-12-25
  • Corresponding author: Xinjun Liang
  • About author:
    Corresponding author: Liang Xinjun, Email:
引用本文:

梁新军, 臧爱华. 长链非编码RNA在结直肠癌中的研究现状[J/OL]. 中华结直肠疾病电子杂志, 2016, 05(06): 518-522.

Xinjun Liang, Aihua Zang. Research progress of long non-coding RNA in colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(06): 518-522.

近年来研究发现,长链非编码RNA在多种恶性肿瘤的发生发展中发挥重要作用,有望成为新的肿瘤治疗靶点,已成为目前肿瘤研究的热点问题之一。本文对长链非编码RNA的概况及其在结直肠癌预后判断、恶性潜能及诊断中的应用现状做一综述,为结直肠癌的精准治疗提供新的思路与依据。

As long non-coding RNA plays an important role in the occurrence and development of a variety of malignant tumors, it has become one of the extensively attended issues in cancer research and is expected to become a new target for tumor therapy. In this review, we outlined the biological characteristics of long non-coding RNA and its application in prognostic value, malignant potential and diagnosis of colorectal cancer, which will provide a new idea and basis for the accurate treatment of colorectal cancer.

[1]
Goldstein DA,Ahmad BB,Chen Q, et al. Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer[J]. J ClinOncol, 2015, 33(32): 3727-3732.
[2]
Chibaudel B,Bonnetain F,Tournigand C, et al. Maintenance treatment in metastatic colorectal cancer[J]. Lancet Oncol, 2015, 16(16): e583-584.
[3]
Huarte M. The emerging role of lncRNAs in cancer[J]. Nat Med, 2015, 21(11): 1253-1261.
[4]
Ruan X. Long non-coding RNA central of glucose homeostasis[J]. J Cell Biochem, 2016, 117(5): 1061-1065.
[5]
Bhan A,Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer[J]. Biochim Biophys Acta, 2015, 1856(1): 151-164.
[6]
Shahryari A,Jazi MS,Samaei NM, et al. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis[J]. Front Genet, 2015, 6: 196.
[7]
Liz J,Esteller M. lncRNAs and microRNAs with a role in cancer development[J]. Biochim Biophys Acta, 2016, 1859(1): 169-176.
[8]
Wu T,Yin X,Zhou Y, et al. Roles of noncoding RNAs in metastasis of nonsmall cell lung cancer: A mini review[J]. J Cancer Res Ther, 2015, Suppl 1: C7-10.
[9]
Malih S,Saidijam M,Malih N. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy[J]. Tumour Biol, 2016, 37(2): 1479-1485.
[10]
Shih JW,Wang LY,Hung CL, et al. Non-coding RNAs in castration-resistant prostate cancer: regulation of androgen receptor signaling and cancer metabolism[J]. Int J Mol Sci, 2015, 16(12): 28943-28978.
[11]
Shi X,Sun M,Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases[J]. Cancer Lett, 2013, 339(2): 159-166.
[12]
Guo F,Guo L,Li Y, et al. MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation[J]. Int J Clin Exp Pathol, 2015, 8(12): 15903-15910.
[13]
Konishi H,Ichikawa D,Yamamoto Y, et al. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma[J]. Cancer Sci, 2016, 107(2): 149-154.
[14]
Xiao H,Tang K,Liu P, et al. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma[J]. Oncotarget, 2015, 6(35): 38005-38015.
[15]
Zheng HT,Shi DB,Wang YW, et al. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer[J]. Int J Clin Exp Pathol, 2014, 7(6): 3174-3181.
[16]
Wu S,Zheng C,Chen S, et al. Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acutebmyeloidleukemia[J]. Oncol Lett, 2015, 10(4): 2410-2414.
[17]
Wang YL,Overstreet AM,Chen MS, et al. Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR[J]. Oncotarget, 2015, 6(13): 11150-11161.
[18]
Wang Y,Wang H,Song T, et al. HOTAIR is a potential target for the treatment of cisplatin resistant ovarian cancer[J]. Mol Med Rep, 2015, 12(2): 2211-2216.
[19]
Svoboda M,Slyskova J,Schneiderova M, et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients[J]. Carcinogenesis, 2014, 35(7): 1510-1515.
[20]
Wu ZH,Wang XL,Tang HM, et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer[J]. Oncol Rep, 2014, 32(1): 395-402.
[21]
Yue B,Sun B,Liu C, et al. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer[J]. Cancer Sci, 2015, 106(10): 1323-1332.
[22]
Yue B,Qiu S,Zhao S, et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J]. J Gastroenterol Hepatol, 2016, 31(3): 595-603.
[23]
Yan B,Gu W,Yang Z, et al. Down regulation of a long noncoding RNA-ncRuPAR contributes to tumor inhibition in colorectalcancer[J]. Tumour Biol, 2014, 35(11): 11329-11335.
[24]
Ren YK,Xiao Y,Wan XB, et al. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer[J]. Int J Clin Exp Pathol, 2015, 8(9): 11458-11463.
[25]
He X,Tan X,Wang X, et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion[J]. Tumour Biol, 2014, 35(12): 12181-12188.
[26]
Qi P,Xu MD,Ni SJ, et al. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients[J]. Mol Carcinog, 2015, 54(9): 742-750.
[27]
Yuan Z,Yu X,Ni B, et al. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis[J]. Int J Oncol, 2016, 48(6): 2675-2685.
[28]
Thorenoor N,Faltejskova-Vychytilova P,Hombach S, et al. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer[J]. Oncotarget, 2016, 7(1): 622-637.
[29]
Sun L,Xue H,Jiang C, et al. LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo[J]. 2016, 36(3): pii: e00328.
[30]
Zhang ZY,Lu YX,Zhang ZY, et al. Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer[J]. Oncotarget, 2016, 7(16): 22639-22649.
[31]
Bian Z,Jin L,Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J]. SCI Rep, 2016, 6: 23892.
[32]
Xiong W,Jiang YX,Ai YQ, et al. Microarray analysis of long non-coding RNA expression profile associated with 5-Fluorouracil-based chemoradiation resistance in colorectal cancer cells[J]. Asian Pac J Cancer Prev, 2015, 16(8): 3395-3402.
[33]
徐小雯,袁捷,左志贵, 等. 与放疗抵抗相关的长链非编码RNA在不同放疗敏感性结直肠癌细胞株中的表达[J]. 中华胃肠外科杂志, 2014, 17(11): 1096-1101.
[34]
Sun QL,Zhao CP,Wang TY, et al. Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing[J]. Gene, 2015, 572(1): 79-86.
[35]
Zhao W,Song M,Zhang J, et al. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma[J]. Int J Clin Exp Pathol, 2015, 8(11): 14131-14140.
[36]
Kam Y,Rubinstein A,Naik S, et al. Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons[J]. Cancer Lett, 2014, 352(1): 90-96.
[37]
Tao K,Yang J,Hu Y, et al. Clinical significance of urothelial carcinoma associated 1 in colon cancer[J]. Int J Clin Exp Med, 2015, 8(11): 21854-21860.
[1] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[2] 王雅楠, 刘丹, 曹正浓, 贾慧敏. 儿童迟发性先天性膈疝患儿的临床诊治特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 410-419.
[3] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[6] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[7] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[8] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[9] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[10] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[11] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[12] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[13] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[14] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[15] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?